会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • TREATMENT OR REDUCTION OF MENOPAUSAL SYMPTOMS
    • 治疗或减少男性症状
    • US20110312906A1
    • 2011-12-22
    • US13167439
    • 2011-06-23
    • Graham E. Kelly
    • Graham E. Kelly
    • A61K31/7048A61P5/24A61K31/352
    • A61K31/353A61K31/35A61K31/352Y10S514/899A61K2300/00
    • There is described a method for the treatment or prevention of menopausal symptoms or osteoporosis wherein there is administered to a subject in need of such treatment a therapeutically effective amount of the isotlavone formononetin, or a method for the treatment or prevention of menopausal symptoms wherein there is administered to a subject in need of such treatment a therapeutically effective amount of the isoflavone daidzein, the isotlavone being optionally administered with one or more pharmaceutically acceptable adjuvants, carriers and/or excipients. Therapeutic uses and compositions/foods are also described, comprising daidzein or formononetin optionally in association with one or more pharmaceutically acceptable adjuvants, carriers, food components and/or excipients.
    • 描述了一种治疗或预​​防绝经症状或骨质疏松症的方法,其中向需要这种治疗的受试者施用治疗有效量的异黄酮黄酮生物素,或用于治疗或预防绝经症状的方法,其中存在 向需要这种治疗的受试者施用治疗有效量的异黄酮黄豆苷原,所述异黄酮任选地与一种或多种药学上可接受的佐剂,载体和/或赋形剂一起施用。 还描述了治疗用途和组合物/食物,其包含任选地与一种或多种药学上可接受的佐剂,载体,食物组分和/或赋形剂结合的黄豆苷原或海参素。
    • 4. 发明授权
    • Treatment or prevention of osteoporosis
    • 治疗或预防骨质疏松症
    • US06340703B1
    • 2002-01-22
    • US09077590
    • 1998-06-02
    • Graham E. Kelly
    • Graham E. Kelly
    • A61K31352
    • A61K31/353A61K31/35A61K31/352Y10S514/899A61K2300/00
    • There is described a method for the treatment or prevention of menopausal symptoms or osteoporosis wherein there is administered to a subject in need of such treatment a therapeutically effective amount of the isoflavone formononetin, or a method for the treatment or prevention of menopausal symptoms wherein there is administered to a subject in need of such treatment a therapeutically effective amount of the isoflavone daidzein, the isoflavone being optionally administered with one or more pharmaceutically acceptable adjuvants, carriers and/or excipients. Therapeutic uses and compositions/foods are also described, comprising daidzeii or formononetin optionally in association with one or more pharmaceutically acceptable adjuvants, carriers, food components and/or excipients.
    • 描述了治疗或预防绝经症状或骨质疏松症的方法,其中向需要这种治疗的受试者施用治疗有效量的异黄酮异黄酮酮,或用于治疗或预防绝经症状的方法,其中存在 向需要这种治疗的受试者施用治疗有效量的异黄酮黄豆苷原,所述异黄酮任选地与一种或多种药学上可接受的佐剂,载体和/或赋形剂一起施用。 还描述了治疗用途和组合物/食物,其包含任选地与一种或多种药学上可接受的佐剂,载体,食物组分和/或赋形剂相关联的大豆黄单胞菌属(Daidzeii)或海参素(formononetin)。